GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$37.56 USD
+0.41 (1.10%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $37.55 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
For GSK PLC Sponsored ADR, the company has a dividend yield of 4.60% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GSK 37.56 +0.41(1.10%)
Will GSK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GSK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GSK
Company News for Jul 31, 2025
GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
GSK: What are Zacks experts saying now?
Zacks Private Portfolio Services
GSK (GSK) Q2 Earnings and Revenues Beat Estimates
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth
Other News for GSK
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Experts helping vaccine advisors are reportedly ousted at CDC
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
European pharmaceutical stocks slip after Trump pushes for lower drug prices